Idexx drops Schein

Idexx Laboratories (NASDAQ:IDXX) informs distributor Henry Schein (NASDAQ:HSIC) that it intends to sell its vet diagnostic products directly in the U.S. effective January 1, 2015. This will eliminate ~$150M in top line sales for Schein and $0.04 - 0.06 in EPS. The company does not forecast a negative impact on 2014 results, however, because it will pick up other brands to sell in the meantime.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs